# #
WELCOME OMNIPOD® SYSTEM USERS

We’re here to make sure you get the support you need as we set up our Customer Care team in Europe.
This information is intended only for existing Omnipod® System customers in Europe. The health information and other information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider and other professional advisors. All decisions regarding patient care must be made with a healthcare provider.
CONTACT US
Want to get in touch with our Customer Care team? Our trained advisors are available to answer any questions you may have about our plans in Europe. Please contact us Monday-Friday from 9am-6pm CET and we will be happy to assist you*.
Austria
0800 281 248
Netherlands
0800 0229512
France
0800 918442
Switzerland
0800 89 76 18
Germany
0800 1821629
United Kingdom
0800 011 6132
(Monday-Friday, 8am-5pm GMT)

*Your call may be monitored and recorded for quality monitoring purposes. Calls to 0800 numbers are free from local landlines, but other networks may charge for these calls.

If you would to speak to someone about any product issues, please be sure to contact your existing supplier as our Customer Care team will not be onboarding customers until 1st July 2018.

WE LISTEN TO OUR CUSTOMERS
<
>
Hear from Shacey Petrovic, Insulet’s President and Chief Operating Officer as well as members from the Insulet International team.
HELP AND SUPPORT
As the developer and manufacturer of the Omnipod® System, we will be taking over all customer support and product services from 1st July 2018. Until then, your distributor will remain the same. To make sure you get the information you need, check out some of our frequently asked questions.
Is the Omnipod® System the same product as the mylife OmniPod®? ^
Yes. The Omnipod® System is the same product as mylife OmniPod® and has always been manufactured by Insulet.
How will this transition affect the supply of my Omnipod® products? ^
This transition will not affect the supply of your Omnipod® products. Insulet is committed to working closely with Ypsomed to ensure continuity of care for Omnipod® System users.
Does my point of contact change? ^
No. Your existing point of contact will remain the same during the transition period. You should continue to contact Ypsomed for any product enquiries or customer service needs.
Whom should I speak to about any product issues? ^
Ypsomed will continue to operate as your point of contact until 1st July 2018. Please continue to use the following numbers for any product enquiries or customer service needs:
  • Austria: (+43) 00800 55 00 00 00
  • France: 0800 883 056
  • Germany: (+49) 0800 9776633
  • Italy: (+39) 0332 189 0607
  • Netherlands: (+31) 0800 9776633
  • Sweden: (+46) 020 612 200
  • Switzerland: (+41) 0800 44 11 44
  • UK: (+44) 0344 856 7820
  • General number for Ypsomed AG: (+41) 34 424 41 41

Does this change how I order mylife OmniPod® products?^
No. Ypsomed continues to be responsible for all mylife OmniPod® product orders until 1st July 2018. Users will be given advance notification of any changes to the ordering process to ensure continuity of care.
How do I stay up to date with future developments for the Omnipod® System in Europe? ^
We're here to make sure it's easy for you to keep up to date with our latest plans in Europe. If you want to recieve email updates from the Insulet team and you haven't done so already, please make sure you sign up.
Who is Insulet? ^
Insulet is an innovative medical device company dedicated to making the lives of people with diabetes easier. As developers and manufacturers of the Omnipod® System, our technology has helped over 140,000 people to improve the way they manage their diabetes. Insulet is currently operating in the US and Canada and is setting up operations to support Omnipod® System users in Europe.
What will change from the 1st July 2018? ^
From 1st July 2018, we will publish details of our Customer Care team on our website www.myomnipod.com so you can contact them by phone or by filling out an online form. Information will be provided in your local language and you will be able to speak to one of our trained advisors in your country. Until then, you should continue to contact your existing supplier.
Will Insulet be offering me additional support? ^
We pride ourselves on listening to and supporting our customers every step of the way to continuously improve what we do. From 1st July 2018, our Customer Care team will be available if you have any feedback to share about your Omnipod® System or support services.
Who do I contact from 1st July 2018? ^
From 1st July 2018, we will publish details of our local Customer Care teams on our website www.myomnipod.com so you can contact them via your phone or by filling out an online form. Until then, you should continue to contact your exisiting supplier.
Will your service be as good as the service I get today? ^
From 1st July 2018, you can expect to receive the full standard of care that you have come to rely on. This includes access to round-the-clock customer care designed to make your life easier. If you have any feedback on how we could improve our product or services, our Customer Care team will be happy to hear form you from 1st July 2018 onwards.
CAN'T FIND WHAT
YOU'RE LOOKING FOR?
Get in touch with our Customer Care team. Our trained advisors are available to answer any questions you may have about our plans in Europe. Please contact us Monday-Friday from 9am-6pm CET and we will be happy to assist you*.
Austria
0800 281 248
Netherlands
0800 0229512
France
0800 918442
Switzerland
0800 89 76 18
Germany
0800 1821629
United Kingdom
0800 011 6132
(Monday-Friday, 8am-5pm GMT)

*Your call may be monitored and recorded for quality monitoring purposes. Calls to 0800 numbers are free from local landlines, but other networks may charge for these calls.

If you would to speak to someone about any product issues, please be sure to contact your existing supplier as our Customer Care team will not be onboarding customers until 1st July 2018.

TELL US WHAT
YOU THINK
We’re always listening to our customers and so your feedback really matters to us. Take a moment to let us know what information interests you most and sign up to receive an email when we publish new information on this website.




*Indicates required field

FIND OUT MORE ABOUT US
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. For more information, please visit: www.insulet.com, www.myomnipod.com, and https://www.omnipodeurope.com.*